Treatment of Periodontitis by Tulsi Gel
Non Surgical Treatment Using Tulsi Gel Versus Chlorhexidine Gel as Adjunctive in Treatment of Advanced Periodontitis ( Stage III and Stage IV )
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Faculty of Dentistry, Al-Azhar University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All patients included in this study will be having advancedI Periodontitis
- Aging from 30 to 50 years old
- Free from any local or systemic risk factors that may affect the results of the study.
Exclusion Criteria:
- Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing.
- Pregnant woman and lactating mothers.
- Patients with previous periodontal treatment including scaling and root planning and periodontal surgery in the last 3 and 6 months, respectively.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Tulsi Gel group
Ocimum sanctum
|
After scaling and root debridement, 4% of Tulsi gel will be injected in to the sulcus until it over flooded, at base line, then after one month.
Other Names:
|
|
Active Comparator: Chlorhexidine Gel group
Chlorhexidine
|
After scaling and root debridement, 1% of Chlorhexidine gel will be injected in to the sulcus until it over flooded, at base line, then after one month.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical parameters
Time Frame: 3 months after end of treatment
|
Improvement of the clinical attachment loss in millimeters.
|
3 months after end of treatment
|
|
Clinical parameters
Time Frame: 3 months after end of treatment
|
Improvement of gingival index.
|
3 months after end of treatment
|
|
Clinical parameters
Time Frame: 3 months after end of treatment
|
Improvement of probing depth in millimeters.
|
3 months after end of treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbiological assessment
Time Frame: 3 months after end of treatment
|
Counting microbial colony of Porphyromonas gingivalis
|
3 months after end of treatment
|
|
Microbiological assessment
Time Frame: 3 months after end of treatment
|
Counting microbial colony of Fusobacterium nucleatum
|
3 months after end of treatment
|
|
Microbiological assessment
Time Frame: 3 months after end of treatment
|
Counting microbial colony of Tannerella forsythia
|
3 months after end of treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- P-ME-24-12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.